beta-Alanine

DB03107InvestigationalSmall molecule

beta-Alanine is an amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may... A rare genetic disorder, hyper-beta-alaninemia, has been reported.

Chemical structure of beta-Alanine
Formula / weight
C3H7NO2 · 89.0932 g/mol (avg)
Also known as
3-aminopropanoic acid · 3-aminopropionic acid · β-alanine · β-aminopropionic acid · ω-aminopropionic acid
Code names
FEMA NO. 3252

Resolves to

Compound
UNII11P2JDE17BCAS107-95-9ChEMBLCHEMBL297569ChEBI57966PubChem4755801KEGGC00099
Clinical / RWD
RxNorm61
Structure
InChIKeyUCMIRNVEIXFBKS-UHFFFAOYSA-NSMILESNCCC(O)=O
Targets
P48066SLC6A11P9WIL5panC
Transporters
Q8TF71SLC16A10

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with beta-Alanine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In